Van Andel Research Institute scientist Scott Rothbart, Ph.D., has been awarded a five-year, $2.375 million Maximizing Investigators' Research Award from the National Institute of General Medical Sciences of the National Institutes of Health that will fuel in-depth, multidisciplinary studies into the epigenetic control mechanisms that regulate the genetic code.
Researchers in the Nutritional Sciences department at the University of Wisconsin have uncovered a new connection in the network of checks and balances underlying cellular iron regulation.
MSU biometric expert Anil Jain and doctoral student Joshua Engelsma have for the first time designed and created a fake finger containing multiple key properties of human skin. Commonly called a spoof, this fake finger has been used to test two of the predominant types of fingerprint readers to help determine their resilience to spoof attacks.
Boston Medical Center's (BMC) psychiatry team is studying a drug called lorcaserin, which targets the brain's serotonin receptors and could help reduce cocaine cravings as well as dampen the rewards associated with taking cocaine.
Colorectal cancer is the fourth leading cause of cancer-related deaths worldwide. In a new study, researchers demonstrate for the first time that a previously uncharacterized protein is increased in colon cancer. The protein is immunoglobulin containing proline rich receptor-1 (IGPR-1) which was recently identified in the same laboratory as a cell adhesion molecule.
Specific immune cells have the ability to produce a healing factor that can promote wound repair in the intestine, a finding that could lead to new, potential therapeutic treatments for inflammatory bowel disease (IBD), according to a new research study.
Opening up a new pathway to fight cancer, researchers at the University of Pennsylvania have found a way to target an enzyme that is crucial to tumor growth while also blocking the mechanism that has made past attempts to target that enzyme resistant to treatment. Researchers were able to use this finding to develop a drug that successfully inhibits tumor growth of melanoma as well as pancreatic and colorectal cancer in mice.
Alterations in a naturally occurring chemical in the brain called serotonin have been linked to a number of neuropsychiatric disorders including depression, anxiety and autism. A team of researchers is revealing critical insights into the mechanisms that can drive diminished serotonin signaling during development and in adulthood to provide new ways of treating several widespread neuropsychiatric disorders associated with perturbed serotonin signaling.
Texas Biomed researchers have partnered with researchers at Notre Dame and the CIDR in Seattle to pursue studies in drug resistant malaria.
Researchers at Brown's Center for Long-Term Care Quality and Innovation landed a $3.7 million grant to conduct a pragmatic cluster randomized trial of the MUSIC & MEMORY program at as many as 60 nursing homes.